Resources

Our community of economists and academic leaders from around the United States are united in their belief that more competition, innovation, accountability, consumer choice, and transparency are needed in America’s healthcare sector to improve the health and well-being of every patient.

This Is How President Biden ‘Beat Medicare’

July 9, 2024

His Inflation Reduction Act leaves patients with less access to medicines and higher premiums.

Wall Street Journal

By Tomas J. Philipson

FTC Releases Interim Staff Report on Prescription Drug Middlemen

July 9, 2024

Report details how prescription drug middleman profit at the expense of patients by inflating drug costs and squeezing Main Street pharmacies

Federal Trade Commission

Changes to Medicare Could Make It More Expensive

July 8, 2024

RealClearHealth

By Kirsten Axelsen

Mail-Order Drugs Were Supposed to Keep Costs Down. It’s Doing the Opposite.

June 25, 2024

One employer was paying about $100 for a prescription for a generic antidepressant, though it could be bought elsewhere for about $12

Wall Street Journal

By Jared S. Hopkins

The Opaque Industry Secretly Inflating Prices for Prescription Drugs

June 21, 2024

Pharmacy benefit managers are driving up drug costs for millions of people, employers and the government.

New York Times

By Rebecca Robbins and Reed Abelson
Scroll to Top